» Articles » PMID: 33381513

Nuclear and Mitochondrial Circulating Cell-Free DNA Is Increased in Patients With Inflammatory Bowel Disease in Clinical Remission

Overview
Specialty General Medicine
Date 2020 Dec 31
PMID 33381513
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The role of cell-free DNA (cfDNA) in the pathogenesis of inflammatory bowel disease (IBD) has been recently suggested. The aim of this study was to analyze circulating cfDNA and deoxyribonuclease (DNase) activity in IBD patients in clinical remission. Plasma and serum were obtained from 72 patients with Crohn's disease and 28 patients with ulcerative colitis. Total cfDNA, nuclear DNA (ncDNA), mitochondrial DNA (mtDNA) and DNase activity were measured. IBD patients showed higher levels of both ncDNA and mtDNA compared to healthy controls. Concentration of ncDNA was higher in males compared to females, including patients and healthy controls. However, unlike males higher amount of ncDNA was found in female IBD patients compared to healthy controls. DNase activity was significantly lower in male IBD patients compared with healthy controls. In addition, there was a negative correlation between DNase activity and ncDNA levels in male IBD patients. Herein we present increased amount of circulating ncDNA and mtDNA in IBD patients in clinical remission. Thus, unlike total cfDNA, circulating ncDNA and mtDNA might not represent the optimal biomarkers of disease activity. This is also the first report on sex difference in circulating ncDNA levels, possibly associated with lower DNase activity in males.

Citing Articles

Neutrophil-dependent Mitochondrial DNA Release Associated With Extracellular Trap Formation in Inflammatory Bowel Disease.

Drury B, Chuah C, Hall R, Hardisty G, Rossi A, Ho G Gastro Hep Adv. 2024; 2(6):788-798.

PMID: 39130118 PMC: 11308081. DOI: 10.1016/j.gastha.2023.03.022.


The role of cGAS in epithelial dysregulation in inflammatory bowel disease and gastrointestinal malignancies.

Ramos A, Bizri N, Novak E, Mollen K, Khan S Front Pharmacol. 2024; 15:1409683.

PMID: 39050748 PMC: 11266671. DOI: 10.3389/fphar.2024.1409683.


Dynamic changes in extracellular vesicle-associated miRNAs elicited by ultrasound in inflammatory bowel disease patients.

Tran F, Scharmacher A, Baran N, Mishra N, Wozny M, Chavez S Sci Rep. 2024; 14(1):10925.

PMID: 38740826 PMC: 11091140. DOI: 10.1038/s41598-024-61532-2.


Extrachromosomal Circular DNA: An Emerging Potential Biomarker for Inflammatory Bowel Diseases?.

Petito V, Di Vincenzo F, Putignani L, Abreu M, Regenberg B, Gasbarrini A Genes (Basel). 2024; 15(4).

PMID: 38674347 PMC: 11049804. DOI: 10.3390/genes15040414.


cGAS-STING signaling pathway in intestinal homeostasis and diseases.

Yang Y, Wang L, Peugnet-Gonzalez I, Parada-Venegas D, Dijkstra G, Faber K Front Immunol. 2023; 14:1239142.

PMID: 37781354 PMC: 10538549. DOI: 10.3389/fimmu.2023.1239142.


References
1.
Obermeier F, Dunger N, Deml L, Herfarth H, Scholmerich J, Falk W . CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice. Eur J Immunol. 2002; 32(7):2084-92. DOI: 10.1002/1521-4141(200207)32:7<2084::AID-IMMU2084>3.0.CO;2-Q. View

2.
Vokalova L, Laukova L, Conka J, Meliskova V, Borbelyova V, Babickova J . Deoxyribonuclease partially ameliorates thioacetamide-induced hepatorenal injury. Am J Physiol Gastrointest Liver Physiol. 2017; 312(5):G457-G463. DOI: 10.1152/ajpgi.00446.2016. View

3.
Babickova J, conka J, Janovicova L, Boris M, Konecna B, Gardlik R . Extracellular DNA as a Prognostic and Therapeutic Target in Mouse Colitis under DNase I Treatment. Folia Biol (Praha). 2018; 64(1):10-15. DOI: 10.14712/fb2018064010010. View

4.
Laukova L, Konecna B, Babickova J, Wagnerova A, Meliskova V, Vlkova B . Exogenous deoxyribonuclease has a protective effect in a mouse model of sepsis. Biomed Pharmacother. 2017; 93:8-16. DOI: 10.1016/j.biopha.2017.06.009. View

5.
Hu S, Peng L, Kwak Y, Tekippe E, Pasare C, Malter J . The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense. Cell Rep. 2015; 13(9):1922-36. PMC: 5477202. DOI: 10.1016/j.celrep.2015.10.040. View